Liraglutide reduces HbA1c and bodyweight in type 2 diabetes

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1504, 2005-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pioglitazone, gliclazide: equivalent HbA1c reductions in type 2 diabetes

Inpharma, Vol. 1, Iss. 1485, 2005-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Sibutramine improves insulin sensitivity and reduces bodyweight in obese patients with type 2 diabetes mellitus

Inpharma, Vol. 1, Iss. 1507, 2005-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Liraglutide looking good in type 2 diabetes

Inpharma, Vol. 1, Iss. 1459, 2004-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Liraglutide lightens glycaemic load in type 2 diabetes

Inpharma, Vol. 1, Iss. 1596, 2007-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Liraglutide LEADs the way in type 2 diabetes treatment

Inpharma, Vol. 1, Iss. 1642, 2008-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite